Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

GLOBAL MARKETS-Stocks flatline, bond yields slide as caution replaces vaccine euphoria

Published 2020-11-13, 04:27 a/m
© Reuters.
STOXX50
-
JP225
-
PFE
-
LCO
-
CL
-
EU50
-
DE10YT=RR
-
US10YT=X
-
CSI300
-
MIWD00000PUS
-

* U.S. stock futures edge up as Arizona called for Biden

* World markets flat to weaker but head for weekly gain

* European shares open weaker, China shares tumble on U.S. investment restrictions, bond defaults

(Updates, changes byline, dateline)

By Sujata Rao

LONDON, Nov 13 (Reuters) - Global shares flat-lined on Friday as rising U.S. and European COVID-19 hospitalisations tempered the euphoria over a promising vaccine, though Wall Street looked set for a firmer open on news president-elect Joe Biden was set to cement his election win.

U.S. futures rose 0.5% by 0.830 GMT .EScv1 after Edison Research projected Biden to capture the battleground state of Arizona, further weakening President Donald Trump's efforts to overturn the results of the Nov. 3 election. the pan-European Stoxx 50 .STXEc1 was down 0.2%, just above its opening levels. MSCI's all-country equity index .MIWD00000PUS slipped 0.1%

"You had the news overnight in the U.S. on COVID, which is not that good and that ... provides an opportunity for investors to book some profit post-Pfizer and post-U.S. elections," said Francois Savary, chief investment officer at Swiss wealth manager Prime Partners.

Thursday saw Wall Street end lower on news of rising coronavirus infections and as investors weighed up the schedule for rolling out effective vaccine. Several U.S. states have introduced stricter social distancing rules following reports of record hospitalisations Europe, too, the number of hospitalisations are now higher than at the peak of the first wave and officials said measures to control infections must continue. Federal Reserve Chair Jerome Powell said on Thursday that progress in developing a coronavirus vaccine was welcome news but near-term economic risks remain, underscoring the likely need for additional government stimulus. stocks are up 1.3% for the week, however. They reached record highs on Monday when pharma giant Pfizer (NYSE:PFE) announced its vaccine had been effective in 90% of cases. Russia followed up by reporting its vaccine trial, too, had shown promise.

European markets lost 0.1% to 0.7%, but the STOXX pan-regional index is set for a second week of big gains. It's up 5% so far this week as the vaccine news induces more investors to buy shares in banks and travel firms.

Earlier, Chinese blue-chips .CSI300 lost 1% after the Trump administration said it would ban U.S. investments in firms linked to the Chinese military. A series of high-profile bond defaults by state-owned enterprises also weighed.

Japan's Nikkei 225 .N225 fell 0.57%.

Some investors saw the pullback as a buying opportunity.

"My view is this is the dark just before dawn," said Michael Frazis, portfolio manager at Frazis Capital Partners in Sydney.

"You've got the second wave of coronavirus, new sets of shutdowns, clear problems around the world, travel dropping off again ... But at the same time, we have the strongest possible evidence that we do have a vaccine."

STIMULUS

One sticking point for markets has been the inability of U.S. lawmakers to agree an adequate spending package. The need for this stimulus was highlighted by Thursday data showing a slower pace of jobs recovery and weak inflation.

While Democrats in Congress urged negotiations over a multi-trillion-dollar stimulus plan, top Republicans rejected that as too expensive Treasury yields slid further, with 10-year yields down around one basis point at 0.87%, well off the seven-and-a-half month high of 0.98% hit on Monday US10YT=RR .

The yield curve, a gauge of growth and inflation expectations, has flattened, too (snapback in bond yields) got a further nudge from the softer-than-expected U.S. inflation data for October which were released yesterday, and which tally with a weaker economic reality," ING Bank analysts said.

Germany's 10-year yield slipped 1.5 bps at -0.54%, moving off this week's two-month highs DE10YT=RR .

Oil prices remained on track for a second week of gains, but the COVID-19 surge and higher U.S. crude stockpiles pushed Brent futures 1% lower LCOc1 to $43 a barrel O/R

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j Yields on longer-dated Treasury debt

https://tmsnrt.rs/3koq9py S&P 500 sectors gain amid vaccine hopes

https://tmsnrt.rs/3eGGlBa

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.